Clinical Trial Update: Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating chemo-immunotherapy followed by durvalumab and Ceralasertib in treatment-naïve patients with extensive-stage small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Ceralasertib (ceralasertib)
• Durvalumab (durvalumab)

Snippet

Sponsor: Muhammad Furqan | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: RECRUITING